Somerset Skin Centre Report issue

Academic/Hospital Phase 3 Phase 4

Organization Overview

First Clinical Trial
2010
NCT01138735
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2011

Timeline

NOW
  • Now

Alternative names

Dermcenter PC - Somerset Skin Centre | Dermcenter PC; Somerset Skin Centre

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Acne Vulgaris (Phase 4)

Erythema (Phase 3)

Psoriasis (Phase 3)

Rosacea (Phase 3)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 3
  • # of Trial APIs: 5